Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases.
Köhler
H
H
Department of General Surgery, University of Göttingen, Germany.
Nustede
R
R
Streich
R
R
Lüdtke
F E
FE
D000818:Animals; D002766:Cholecystokinin / Q000097:blood / Q000502:physiology*; D004285:Dogs; D004386:Duodenum / Q000187:drug effects / Q000502:physiology*; D004952:Esters; D005402:Fistula; D016670:Gabexate / Q000031:analogs & derivatives*; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000494:pharmacology; D006146:Guanidines / Q000008:administration & dosage / Q000494:pharmacology*; D007136:Immunoglobulins / Q000494:pharmacology; D007262:Infusions, Intravenous; D010179:Pancreas / Q000187:drug effects / Q000502:physiology* / Q000601:surgery; D010455:Peptides / Q000097:blood / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism
D004952:Esters; D005755:Gastrins; D006146:Guanidines; D007136:Immunoglobulins; D010455:Peptides; D011480:Protease Inhibitors; D011506:Proteins; C034532:camostat; D016670:Gabexate; D019886:Gastrin-Releasing Peptide; D002766:Cholecystokinin